Metformin reduces glycometabolism of papillary thyroid carcinoma in vitro and in vivo. [electronic resource]
Producer: 20171026Description: 15-23 p. digitalISSN:- 1479-6813
- AMP-Activated Protein Kinases -- metabolism
- Animals
- Carcinoma, Papillary -- diagnostic imaging
- Cell Line, Tumor
- Cell Survival
- Disease Models, Animal
- Female
- Fluorodeoxyglucose F18
- Gene Expression
- Glucose -- metabolism
- Glucose Transporter Type 1 -- genetics
- Heterografts
- Hexokinase -- genetics
- Humans
- Immunohistochemistry
- Metabolic Networks and Pathways -- drug effects
- Metformin -- pharmacology
- Positron Emission Tomography Computed Tomography -- methods
- Proto-Oncogene Proteins c-akt -- metabolism
- Signal Transduction
- TOR Serine-Threonine Kinases -- metabolism
- Thyroid Cancer, Papillary
- Thyroid Neoplasms -- diagnostic imaging
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.